Lipid storage · Menopause · Obesity · Exercise · Metabolic profile Summary Objective: The aim of this study was to examine regional variation in adipose tissue lipoprotein lipase (AT-LPL) activity and expression in pre-and postmenopausal women, before and after training, once differences in chronological age or obesity degree are taken into account. Methods: Sixteen late pre-and 14 early postmenopausal (49 ± 2 vs. 52 ± 2 years; p < 0.001) moderately obese women (body mass index 29-35 kg/m 2 ) were subjected to a 16-week walking program (3 sessions/week of 45 min at 60% heart rate reserve). Abdominal and femoral AT-LPL activity and expression, fasting lipidlipoprotein profile, body composition, and cardiorespiratory fitness (CRF) were measured before and after our intervention. Statistical analyses were performed using covariance analysis for age differences. Results: AT-LPL activity and expression, lipid-lipoprotein metabolism, body fatness, and CRF were similar at baseline, irrespective of the group considered. Slight reductions in plasma cholesterol and high-density lipoprotein (HDL) cholesterol levels, fat mass and waist girth reductions, CRF increases as well as femoral AT-LPL activity and expression decreases after our intervention were comparable, regardless of menopausal status (0.0001 < p < 0.05).
Introduction
Numerousstudieshavealreadypointedoutthatpremenopausalwomentendtoaccumulateexcessfatpredominantlyinthe gluteo-femoralareaswhichmay,toacertainextent,becardioprotective,whilepostmenopausalwomendisplayapreferentialabdominalfatdepositionassociatedwithanincreasedrisk ofmetaboliccomplications [1, 2] .Inthisregard,regionalvariationinadiposetissuelipoproteinlipase(AT-LPL)activity,a keyregulatoroflipidstorage [3] ,hasalreadybeenhypothesizedtoaccountfordifferencesinbodyfatdistributionoccurringduringthetransitiontomenopause [4] .Indeed,AT-LPL activityishigherinthegluteo-femoralthanintheabdominal region in premenopausal women [5] [6] [7] [8] , although discordant resultsconcerningthepresence [6, 9] orabsenceofregional variationinthisenzymeactivitywerereportedinpostmenopausal women [7, 10, 11] . Main reasons for these conflicting data could be i) the lack of clear identification of women beingintheirperimenopausalphase [9] ,ii)thatpremenopausal women were examined in the luteal phase [6] or at any point of their menstrual cycle [7] , iii) the use or not of hor-*Bothco-authorsequallycontributedtothiswork.
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ObesFacts2010; 3:191-199 Tessier/Riesco/Lacaille/Pérusse/Weisnagel/ Doré/Mauriège monetherapy(HT)bywomenatmenopause [7, [11] [12] [13] ,and iv) that pre-and postmenopausal women studied were not matchedforage,adiposity,andregionalfatdistribution [6, 7] . TheexistenceofsitedifferencesinAT-LPLmRNAlevelshas alsobeendocumentedinpre- [5, 14] butnotinpostmenopausal women. However, the regulatory effects of ovarian hormone deficiency on regional variation in AT-LPL activity and/or expression has never been investigated, once differencesinwomen'schronologicalageand/orobesitydegreeare takenintoaccount.
On the other hand, previous studies that assessed the impact of different weight loss strategies including surgery, hypocaloricdietaloneorcombinedwithdrugsoraerobicexerciseonAT-LPLactivity,haveshowneitheradecrease [15] or alackofchange [10, 16, 17] ,whereasothershaveobservedan increaseintheenzymeactivity [18] [19] [20] .Verylittleinformation ontheeffectofaerobicexercisealoneonAT-LPLactivityis, however,availablewiththeexceptionofonestudy [21] which clearlyreportedadecreaseinthisenzymeactivityatboththe abdominalandfemoralsites,after6monthsofenduranceex-ercise,inobesepremenopausalwomen.AsLPLplaysanimportantroleinlipoproteinmetabolismbycatabolizingchylomicrons and very-low-density lipoprotein (VLDL) thus leadingtotheformationofhigh-densitylipoprotein(HDL)cholesterolparticles [22] ,wewonderedwhetherchangesinthisenzymeactivityand/orexpressioncouldhaveanimpactonlipidlipoproteinmetabolism. However,theimpactofaphysicalactivitydifferentfromastandardizedlaboratoryexerciseonregionalvariationinAT-LPLactivityand/orexpressionhasnot yet been investigated in pre-and postmenopausal women carefullymatchedforageandobesitydegree.
Primary aims of this study were thus i) to verify whether regional variations in both AT-LPL activity and expression persistatearlymenopausewhencomparedtolatepremenopausal status, once age and obesity degree differences are takenintoaccount,andii)toevaluatetheimpactofa16-week walking program on AT-LPL activity and mRNA level. A secondary objective was to examine whether changes in the enzymeactivityand/orexpressionwererelatedtoamorefavourableordeleteriouslipid-lipoproteinprofile.
Material and Methods

Subjects
Healthy Caucasian women were recruited from the suburbs of Québec Citytoparticipateina16-weekwalkingprogram,theMenopauseObesity andExercisestudy(MenOEx),throughanannouncementinlocalnewspapers.Fromatotalof48womenwhoresponded,35participantsmetthe followinginclusioncriteria:Noneofthewomenhadidentifiedcardiomyopathy,endocrinedisorderswhichmayhavecausedirregularmenstrual cycles,ororthopaediclimitationsthatwouldaffectphysicalactivity.They hadtobenon-smokersandmoderateconsumersofalcoholandcaffeine. Theirbodyweighthadtobestable(lessthan2kgweightchange)inthe yearbeforetheonsetofthestudy. Allparticipantsalsohadtobesedentary(exercisinglessthan30minperweek),andmoderatelyobese(body massindex(BMI)rangingfrom29to35kg/m 2 ).Womenonmedication that could potentially influence the outcome of this study (b-blockers, sympathomimetics,cholesterol-loweringdrugsincludingstatins,corticosteroids,antihypertensivedrugs,andthyroxineforwhichadosagechange occurredduringthelast6months)wereexcludedfromthepresentstudy. Premenopausalstatuswasdefinedastheoccurrenceof2mensesinthe 3lastmonths,theabsenceofcycleirregularityinthe12monthspreced-ingtesting,meancyclelengthof24-30days,andplasmafollicle-stimulating hormone (FSH) levels lower than 30-40 IU/l. In this regard, all premenopausal women from the present study had plasma FSH levels lower than 40 IU/l. In addition, postmenopausal status was defined by amenorrheaforatleast12monthsbutnolongerthan5years,andplasma FSHlevelsgreaterthan30-40IU/l (NorthAmericanMenopauseSociety, 2000) . In this regard, Henrich et al. [23] have already shown the existenceofaconsiderableoverlapamongdistributionsofFSHbystageon arepresentativesampleof576USwomenaged35-60yearsexamined during the National Health and Nutrition Examination Survey (NHANES)1999-2000.Indeed,FSHcut-offpointsbetweenthereproductiveandmenopausetransitionstagesaswellasbetweenthemenopausetransitionandpostmenopausalstageswereneithersensitivenor veryspecific,thusemphasizingthatFSHlevelshadlimitedutilityindiscriminatingamongwomenindifferentstages.Althoughthephysiologicalandclinicalmanifestationsoftransitiontomenopausearestillnotwell understood, perimenopause, a time of menstrual irregularity lasting between2and8years [24] [25] [26] ,seemstooccurinstages.Duringperimenopause,FSHconcentrationsmayraisetothepostmenopauserangeduring some cycles, but return to premenopausal levels during subsequent cycles.AsFSHlevelsalsofluctuatefrommonthtomonthduringthisphase [24, 25] ,theperimenopausalstatuscannotthusbeclearlyestablished.Itis the reason why perimenopausal women with irregular menses were excludedfromourstudy.AccordingtotheStagesofReproductiveAging Workshop (STRAW), late premenopausal (e.g. reproductive) stage referstowomenwithregularmenstrualcyclesassociatedwitheithernormalorslightlyincreasedplasmaFSHlevels [27] .Finally,premenopausal women using oral contraceptives and postmenopausal women on HT wereexcludedfromthepresentstudy(table1).
Study Design
The experimental design was approved by the University Ethical Committee on Human Research for Medical Sciences, and all participants gave their written informed consent to participate in this study, conformedtotheLavalUniversityMedicalEthicsCommittee.Beforeenteringourprotocol,allwomenhadaphysicalexaminationwhichincludeda restingelectrocardiogram,byourphysicians.Theexerciseprogramwas plannedaccordingtotheAmericanCollegeofSportsandMedicinerecommendations [28] ,andconsistedof3non-consecutivesessions/weekof 45minwalkinginindoorcommunityfacilities(PEPS),atapproximately 60%ofheartrate(HR)reserve(HRR)(e.g.themaximalHRminusthe restingHR),during16weeks.MaximalHRwascalculatedfromthefollowingequation:220-age,whereageisexpressedinyears.WalkingHR wascalculatedaspercentageHRR+restingHR,accordingtoKarvonen etal. [29] .The3-weeklywalkingsessionsweresupervisedbyanexercise leader.Fromthe35women(18pre-and17postmenopausal)whobegan theenduranceexerciseprogram,16latepremenopausalwomen,49±2 yearsold(mean±standarddeviation,SD),and14earlypostmenopausal women52±2yearsoldcompletedourstudyandhadthepre-andpostinterventionfatbiopsies.Reasonsfordropoutof2pre-and3postmeno-pausalwomenwereillness(n=1),re-location(n=1),orwishtoperform moreexercisethanthe3sessions/weekplanned(n=3).
Adipose Tissue Biopsy Procedure and Lipoprotein Lipase Activity
Afteranovernightfast,participantsweresubjectedtobiopsiesofsubcutaneousfat,oneperformedintheperiumbilicalregion(abdominalsite)and the other at the anterior midthigh level (femoral site). Local anaesthesia (1% xylocaine, without epinephrine) was performed in such a way that it ObesFacts2010; 3:191-199 WalkingandLipidStorageinObeseWomen 193 measuredatthenarrowestcircumferenceofthetrunkaccordingtostandardizedprocedures.SincethepioneeringworkofLemieuxetal. [34] ,waist circumferencewasshowntobeastrongeranthropometriccorrelateofabdominalvisceralATthanwaist-to-hipratio(WHR)asitdidnotappearto besignificantlyinfluencedbygendernorbytheobesitydegree.Moreover, the use of waist girth instead of WHR to more accurately estimate the crude visceral abdominal fat accumulation and its related coronary heart disease risk has been largely emphasized during the last decade, as waist circumference is one of the 5 clinical criteria selected to determine the presenceofmetabolicsyndrome,accordingtotheNCEP-ATPIIIguidelines(2001) [35] .Fatmassandleanmassweredeterminedbyastandard bioelectricalimpedancetechnique(Bodystat1500,IsleofMan,UK) [36] . Allmeasurementswereperformedintriplicate,andthenaveraged.
Cardiorespiratory Fitness
Cardiorespiratory fitness (CRF) was assessed by the 2-km walking test which was validated on moderately fit and obese but otherwise healthy menandwomen20-65yearsold [37] .Estimatedmaximaloxygenuptake V O 2 max (ml/kg/min) was calculated based on sex-specific prediction modelswhichincludedwalkingtime,HRattheendofthewalk,age,and BMI. Equation used to predict V O 2 max in women was the following: V O 2 max(ml/kg/min)=116.2-2.98×time-0.11×HR -0.14×age-0.39 ×BMI,wheretimeistheelapsedtimeforawalkinminutes,HRisthe value at the end of the walk (beats/min), age is expressed in years and BMIinkg/m 2 .
Plasma Determinations
Blood was collected from an antecubital vein in the morning after a 12-hour overnight fast and a 15-min rest period, and plasma samples were storedat-80ºCuntiluse.Womenhadtoremaininactivefor36htoelimi-nateanyacuteeffectofexerciseonthemetabolicprofilebeforeourpostintervention [31] .Fastingtotalcholesterol,triacyglycerol(TAG)andHDL cholesterol levels were determined according to standardized laboratory procedures on a Technicon RA-500 analyzer (Bayer, Tarrytown, NJ, USA). Apolipoprotein B was measured by nephelometry (BN ProSpec; Dade Behring, Newark, DE, USA) with reagents provided by this company(NAntiseratoHumanApolipoproteinB).Fastinglow-densitylipoprotein(LDL)cholesterolconcentrationswereestimatedusingtheFriedewaldequation [38] . PlasmaFSHconcentrationsweredeterminedbyaradioimmunoassaykit(DiagnosticSystemLaboratories,Webster,TX,USA) whileestradiollevelsweremeasuredbyacompetitiveimmunologicalassay (Immuno-1 apparatus, Bayer). Fasting blood sample measurements were performedirrespectiveofpremenopausalwomen'smenstrualcycle.
didnotinfluencethemetabolicactivityofexcisedadiposetissue(AT) [30] . Biopsieswereperformedbeforeand2-4weeksaftertheendofthetraining period.Allwomenhadtoremaininactivefor36htoavoidacuteeffectof exerciseonATmetabolismbeforeourpost-intervention [31] .Forpremenopausal women, biopsies were performed while they were in the follicular phase of their menstrual cycle (e.g. between the 5th and the 12th days of theirmenstrualcycle).Approximately100mgofATfromeachregionwere immediately frozen in liquid nitrogen for later measurement of heparinreleasablelipoproteinlipase(LPL)activity,accordingtoImbeaultetal. [5] , andallexperimentswereruninduplicates.[ 14 C]-trioleinwasobtainedfrom Perkin-ElmerandAnalyticalSciences (Woodbridge,ON,Canada)whereas cold triolein came from Sigma-Aldrich (Oakville, ON, Canada). Another sampleof250mgATwasusedformeasurementoffatcellsize.Adipocytes wereisolatedbycollagenasedigestion,andmeanadiposecelldiameterwas assessedfromthemeasurementof300cells [30] .
RNA Preparation and Quantification of Lipoprotein Lipase mRNA Levels
Briefly, about 5-10 mg of total RNA was extracted from AT samples of 100mg,usingRNeasyMiniKit(Qiagen,Mississauga,ON,Canada).The averageyieldoftotalRNAwas2.40±0.86and2.80±1.66mg/100mgAT (mean±SD),forbiopsiesperformedbeforeandafterourintervention,respectively. First, 1 mg of total RNA was reverse transcribed into cDNA, using SuperScript II Reverse Transcriptase kit (Invitrogen Canada, Burlington, ON, Canada), and 50 ng of cDNA were used for polymerase chain reaction (PCR). Primer forward and reverse sequences for LPL were5'-ACACAGCTGAGGACACTTGC-3'and5'-CACTGGGTAAT-GCTCCTGAG-3', respectively. PCR consisted in an initial denaturation stepat95°Cfor2min,followedby30cyclescomposedof20sat95°C, 20sannealingat64°C,and20selongationat72°C.Reactionwasheated between72and99°C,risingeachstepby1°Cfor5stoobtainthemelting curveandtoconfirmasingleproductofPCR.AT-LPLmRNAlevelswere quantitatedbyfluorescentPCRonaRotorGene3000(CorbettResearch, MontrealBiotech,Kirkland,QC,Canada),usingtheSYBRGreenJump StartTAQreadymix(Sigma-Aldrich)andnormalizedtoglyceraldehyde phosphate dehydrogenase whose primer forward and reverse sequences were 5'-ATCACCCCTTCATTGACCTCAAC-3' and 5'-GGTTCACAC-CCATGACGAACATG-3', respectively. All measurements were performedinduplicates [32, 33] .
Anthropometry and Body Composition
Bodyweightandheightweremeasuredaspreviouslydescribed [29] Tessier/Riesco/Lacaille/Pérusse/Weisnagel/ Doré/Mauriège (0.18 < p < 0.98). As expected, total adiposity was reduced after training, in both groups. Body weight loss of -2.0 ± 2.2 versus0.6±1.1kg(means±SD)andBMIdecreaseof-0.8± 0.9 kg/m 2 versus -0.3 ± 0.4 kg/m 2 were higher in pre-than in postmenopausal women, respectively (0.005 < p < 0.05). Although fat mass loss was comparable (p < 0.001), lean mass remainedunchangedafterwalking,inbothgroups(p=0.79). Waistgirthwassimilarlyreducedafterourintervention,inall women (p < 0.0001). Finally, subcutaneous abdominal and femoral fat cell weight did not change in response to enduranceexercise,regardlessofmenopausalstatus(0.40<p<0.52). 
Subjects' Hormonal and Lipid-Lipoprotein Profiles
Relationships between Adipose Tissue-Lipoprotein Lipase Activity and Expression
TheextentofthefallinLPLactivityobservedafterourintervention in the femoral (but not in the abdominal) fat depot wasassociatedwiththeinitiallevelofenzymeactivity. Figure  3showsthatthehigherwastheinitialfemoralAT -LPLactivity,thegreaterwasitsreductionwhenexpressedperATmass orpercellnumberinpre-andpostmenopausalwomenconsideredtogether(-0.82<r<-0.74;p<0.0001).Thedecrease infemoralAT-LPLmRNAlevelswasalsonegativelyrelated to the baseline enzyme expression (r = -0.56; p < 0.005). Changes in femoral AT-LPL expression were positively relatedtothoseinitsactivitywhenexpressedperATmass,only (r=0.41;p<0.05).However,therewasnosignificantassociationbetweenfemoralAT-LPLmRNAlevelsandtheenzyme activityassessedatbaseline(-0.23<r<-0.21).Similardata wereobservedattheabdominalsite(notshown).
Relationships between Changes in Adipose TissueLipoprotein Lipase Activity and/or Expression and LipidLipoprotein Metabolism
ReductionsinthefemoralAT-LPLactivityorexpressionwere associated neither with the slight reduction in plasma LDL lesterolandHDLcholesterollevelsweredecreasedinallsubjects(p<0.05),whereasLDLcholesterolconcentrationswere reduced after walking in premenopausal women, exclusively (p < 0.05). Moreover, plasma estradiol levels remained unchangedafterourintervention,inbothgroups. Figure 1 illustrates the effect of our walking program on ATLPLactivityexpressedeitherperATmass,percellnumber,or corrected for variation in cell surface area, in subcutaneous abdominalandfemoraladiposeregionsofpre-andpostmenopausal women. No regional variation was found in the initial AT-LPLactivity,regardlessofdataexpressionandmenopausal status(0.08<p<0.88).AdecreaseinfemoralAT-LPLactivity when expressed per AT mass or cell number was observed in responsetoourintervention,inbothgroups(0.005<p<0.05). However, this enzyme activity measured in the abdominal fat depot did not change after walking, in both groups (0.10 <p<0.33).Asshowninfigure2,AT-LPLexpressionwasalso similarinpre-andpostmenopausalwomen,regardlessofthefat depot (0.15 < p < 0.28). Both pre-and postmenopausal displayedreducedenzymemRNAlevelsatthefemoralsiteafter walking(p<0.01),butnotattheabdominallevel(p=0.42).
Adipose Tissue-Lipoprotein Lipase Activity and Expression
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Abdominal Femoral Fig. 2. Bemaßung 149,6 (Fig. 3. Bemaßung 118,8 Thefactthatfemoral(butnotabdominal)AT-LPLactivity wassignificantlyreducedafterwalking,intheabsenceofreduced fat cell size and despite modest body weight and fat masslosses,couldalsobequestioned.Inthisregard,attention should be paid to the preferential abdominal fat cell weight reductionreportedafterdietcombinedwithaerobicexercise, inobesewomen [43] .Indeed,althoughglutealadipocytesize decreased similarly in response to diet alone or associated witheitherlow-orhigh-intensityexercise,subcutaneousabdominal fat size was preferentially reduced in combined weightlossinterventions [43] . Moreover,thedecreaseinfemoral AT-LPL activity noted after our 16-week walking program is concordant with previous reports [5, 15, 21, 44] but contrastswithotherswhichshowedalackofchange [10, 16, 17] , or an increase in the enzyme activity [18] [19] [20] . Such discrepancy could be due to the substantial mean weight loss achievedreportedinthe3latterstudies [18] [19] [20] ortosubjects' fatness, nature, and duration of the restrictive diet used to promote weight loss, combination of caloric restriction and aerobic exercise [10, 16, 17] . The negative relationship observed between the fall in LPL activity and the pre-weight loss enzyme activity has been frequently observed among studiesreportingadecreaseinAT-LPLactivity [5, 15, 16, 21, 44] . OurresultsalsorevealedareductioninfemoralAT-LPL expressionfollowingenduranceexercise,inbothgroups.Although this result is not in agreement with the similar postweightlossenzymeexpressionreportedbyourgroup [5] ,such discrepancy could be due to the techniques used (Northern blot analysis versus RT-PCR) and/or to women's age differences.Inthepresentstudy,thehigherthedecreaseinfemoral AT-LPLexpression,thegreaterthereductionintheenzyme activity,thussuggestingthatchangesmayoccuratatranscriptionallevel.However,asexpressionofLPLinvolvesseveral steps such as gene transcription, processing, transport, and translation of mRNA as well as post-translational modifications, secretion, and extra-cellular activation of the enzyme [3] should be considered [14, 45] . Further studies measuring AT-LPLmassareneededtoaddressthisissue.
AdecreaseinAT-LPLactivityafterweightlosscouldlead to a reduction in TAG clearance, thus resulting in higher TAGaswellaslowerplasmaHDLandLDLcholesterolconcentrations.Thelackofclearrelationshipsbetweenchanges in plasma TAG levels and variation in AT-LPL activity has already been reported by us [5] and others [16] , in pre-and postmenopausalwomen,respectively.Inthisregard,resultsof studiesinvestigatingtheeffectofcaloricrestrictioncombined withlipid-loweringdrugsorexerciseonplasmaTGlevelsindicatedthatreductionsinfastingTAGlevelswereassociated with skeletal muscle rather than with AT-LPL activity [46] . On the other hand, we did not observe any association betweenvariationinAT-LPLactivityandchangesinLDLand/ orinHDLcholesterollevels,despitetheslightreductionsin these plasma lipoprotein levels after walking (table 3) . This findingisincontrastwiththepositiverelationshipfoundbeicalageandobesitydegree.Ourresultsshowedthattheenzyme activity and its expression in the femoral (but not the abdominal) fat depot decreased similarly in response to our walkingprogram,regardlessofmenopausalstatus.
ThecomparablefatcellsizeandAT-LPLactivitynotedin premenopausalwomen,irrespectiveoftheregionconsidered, isincontrastwithprevious [6, 7] ,butnotallobservations [5, 39] . Controversies between our findings and those of Rebuffé-Scriveetal. [7] couldbeduetothefactthatthelatterpremenopausalwomenwereyounger(meanageof30±2years),leaner (mean BMI of 23.7 ± 0.6 kg/m 2 ) (mean ± SE) than our participants(table2).Also,theirAT-LPLactivitywasmeasuredwhile womenwereeitherinthefollicularorinthelutealphaseoftheir menstrualcycle,Similarly,conflictingdatabetweenourstudyand theoneofRaisonetal. [6] couldbeattributedtodifferencesin women'sage(38±2years)andobesitydegree(35.2±2kg/m 2 ), as well as to the fact that fat biopsies and LPL measurements were done during women's luteal phase (i.e. between the 19th and25thdaysoftheirmenstrualcycle).Inthisregard,ATbiopsies and enzyme assays were performed during the follicular phaseofoursubjects(i.e.,betweenthe5thand12thdaysoftheir menstrual cycle). Although the lack of regional variation in both fat cell weight and enzyme activity of postmenopausal womenhaslargelybeendocumented [7, [11] [12] [13] 39] ,itisnot concordant with some studies [6, 9, 16] probably because of subjects'fatnessandage,durationofmenopause,theuseor notofHT,itsmodeofadministration(oralvs.transdermal), aswellastothefactthatestrogenswereadministeredalone and/orcombinedwithprogesterone.Inthisregard,Rebuffé-Scriveetal. [11] andLindbergetal. [13] clearlyshowedthat HTwasabletorestorehighfatcellsizeandAT-LPLactivity in the femoral depot, when compared to the abdominal region.Thefactthatpre-andpostmenopausalwomenhadcomparablefatcellsizeandAT-LPLactivityiseasilyexplainable bytheirphysicalcharacteristicsatbaseline(table1),andconcordant with previous reports [39, 40] . The lack of regional variationinAT-LPLmRNAabundancecouldalsobepartly explained by subjects' fatness, as Arner et al. [14] already found higher LPL mRNA abundance in the gluteal than in theabdominalregionofpremenopausalnonobesewomen.It issurprisingthatAT-LPLactivitydoesnotvaryaccordingto menopausal status, as plasma estradiol levels differ between pre-and postmenopausal women. However, no relationship wasobservedbetweentheenzymeactivityandplasmaestradiollevelsinthepresentstudy.Inthisregard,highestradiol levelswerealreadyshowntodecreaseabdominalAT-LPLactivitywhilelowdoseshadtheoppositeeffects [41] ,although in vitro incubation of AT fragments with estradiol reduced theenzymeactivity [42] .TheuseofwholeATfragments [42] instead of isolated adipocytes [41] could provide a valuable explanation for these conflicting data. Further experiments that will examine the influence of sex steroids on changes in AT-LPL activity with menopause transition are clearly warranted.
Tessier/Riesco/Lacaille/Pérusse/Weisnagel/ Doré/Mauriège dle-aged and healthy individuals [50] . On the other hand, reductioninfastingcholesterollevelscouldbeprobablyconsidered asnotclinicallyrelevant,asthevaluereported(p=.049)wasof borderlinesignificance.Suchfindingscouldbepartlyexplained bythesmallnumberofparticipants(n=30).Inthisregard,the twosetsoffatbiopsiesplannedbeforeandafterourendurance exerciseprogramrepresentedaninvasiveinterventionwhichmay havelimitedthenumberofvolunteers.Finally,althoughblood samplemeasurementsshouldhavebeenperformedwhilepremenopausalwomenwereinthefollicularphaseoftheirmenstrual cycle (e.g. between the 5th and the 12th days of their menstrualcycle),thiswasnotpossiblebecauseofourparticipants'timeconstraints.Suchanobservationcouldprovidean additionalexplanationtothewiderangeofvariationobserved inplasmaFSHlevels(table3).
Our study also has several strengths such as the fact that women walked in indoor community facilities under the supervisionofanexercisephysiologist,3timesperweek,during whichexerciseintensitywascontinuouslymonitoredthrough HR,andHRvalueswererecordedinanexerciselogbookto ensure compliance with the training intensity. In addition, comparison of late pre-and early postmenopausal women with a narrow age difference allows better understanding of theeffectsofmenopauseonlipidstoragecapacities [40] .
Conclusion
ThisstudydocumentsforthefirsttimethatboththeLPLactivityandmRNAlevelofthefemoral(butnotthesubcutaneousabdominal)ATaresimilar,regardlessofmenopausalstatus,oncechronologicalageandobesitydegreearetakeninto account.Our16-weekwalkingprogramalsoseemstobesufficienttoreducelipidstorageinthefemoralfatdepotoflate pre-andearlypostmenopausalwomen.Finally,reductionin femoralAT-LPLactivitydoesnotleadtoamoredeleterious lipid-lipoprotein profile, despite the modest decrease observedinplasmaHDLcholesterollevels.
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tweenthedecreaseinfemoralAT-LPLactivityandthereduction in plasma HDL cholesterol concentrations after weight loss, already found in young premenopausal women by our group [5] .Althoughnotstatisticallysignificant,similartrends foradecreaseinplasmaHDLcholesterolconcentrationsassociatedwithareductioninglutealAT-LPLactivitywerealreadyobservedinpostmenopausalwomen [16] .Itistruethat a high femoral or gluteal AT-LPL activity in pre-and postmenopausal women may increase the proportion of cholesterolesterremainingassociatedwithHDL,theprotectivelipoprotein fraction against coronary heart disease [8, 12] . Therefore, the decrease in the femoral AT-LPL activity observedinourparticipantscouldbeconsideredasdeleterious fromaclinicalstandpointasHDLcholesterolconcentrations were slightly reduced after walking. However, these values higherthanthethresholddefinedbytheNCEP-ATPIII [35] stillattestedofafavourablelipid-lipoproteinprofile.Finally, womenwhoseabdominalandglutealAT-LPLactivitieswere reducedwithweightlossregainedlessbodyweightatfollowup, thus suggesting that energy storage efficiency was decreasedintheweight-reducedstateofthesewomen [16] .Regarding these findings, it should be thus hypothesized that weightregainwillbelessimportantinourparticipants.
Finally,thedifferencebetweengroupsof7.7%inbaseline HDLcholesterollevels,althoughbeingclinicallymarginal,reflected a favourable lipid-lipoprotein profile, as values recordedwereabovethethresholdof1.3mmol/ldefinedbythe NCEP/ATP III guidelines (2001) [35] . In addition, although waistgirthvalueswereabovetheNCEP-ATPIIIthreshold, thiscriterionsimilarlydecreasedinallwomen,afterourwalkingprogram.However,thefactthatwaistcircumferencewas stillhigherthan88cm,clearlyattestedofasubcutaneousabdominalratherthanavisceralobesity [47] .Indeed,Lemieux et al. [48] have already proposed that the 'hypertriglyceridemic waist' (e.g. elevated waist circumference combined withhighfastingTAGlevels)shouldbetteridentifyindividualswithanexcessivevisceralfataccumulationandtherelated featuresofmetabolicsyndrome.AsplasmaTAGlevelswere belowthethresholdof1.7mmol/l [35] ,ourparticipantswere probablycharacterizedbyasubcutaneousabdominalformof obesity,irrespectiveoftheirmenopausalstatus.
Somelimitationsmay,however,deservefurtherattention. Indeed,bioelectricalimpedancewasusedtoassessbodycompositioninsteadofothermethodsmoresophisticatedsuchas DEXA. However, leg-to-leg bio-impedance has been validated during weight loss interventions conducted in overweight and obese individuals [49] . Estimated V O 2 max was alsoextrapolatedfromthe2-kmwalkingtest(asub-maximal exercise test), and some error should have thus been introducedastheequationusedtopredictV O 2 maxtookintoaccountvariablessuchaselapsedtimeandHRattheendofa 2-km walk, and BMI [37] . However, the 2-km walking test wasconsideredbythesamegroupasavalidtoolforpredictingV O 2 max changesaftera15-weekwalkingprograminmid-
